Company Overview and News
LONDON (Reuters) - Sky (SKYB.L) said on Monday that it expected to pay its advisers between 90 million pounds and 97 million pounds ($123.7 million) if Twenty-First Century Fox (FOXA.O) succeeds with its takeover of the British broadcaster.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems (CSCO), AstraZeneca (AZN) and Enbridge (ENB). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
LMT HD FOX DB SAPGF AZN ENB MPC SE ENB SAP AZN CSCO MS OXY FOXA
Indian video streaming service Hotstar sees its blended revenue model that relies on both subscription fees and ad sales as a winning formula in India's fast growing market, home to tens of millions of price sensitive new internet users.
Congratulations are in order for Disney (NYSE:DIS) after it won the bidding war for Fox’s (NASDAQ:FOXA) assets. Disney beat the competition, enabling it to bring home the bulk of the assets. On the other hand, it had to pay a large amount of money to seal the deal. Did Disney make a shrewd move or was its offer too undisciplined? That’s not the only question which will affect DIS stock going forward.
CMCSA NFLX FOXA DIS
MUMBAI: Indian video streaming service Hotstar sees its blended revenue model that relies on both subscription fees and ad sales as a winning formula in India's fast-growing market, home to tens of millions of price-sensitive new internet users.
WASHINGTON (Reuters) - White House counsel Don McGahn called the head of Federal Communications Commission in July to ask about the status of Sinclair Broadcast Group Inc’s (SBGI.O) now abandoned $3.9 billion acquisition of Tribune Media Co (TRCO.N).
FOX TRBNW SBGI FOXA TRCO TRBAB
White House counsel Don McGahn called the head of Federal Communications Commission in July to ask about the status of Sinclair Broadcast Group Inc’s now abandoned US$3.9 billion acquisition of Tribune Media Co .
FOX TRBNW SBGI FOXA TRCO TRBAB
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot (HD), United Parcel Service (UPS) and Occidental Petroleum (OXY). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
SGEN HD CVS HSB CME MS HSBC HBCYF FOX UPS HCS 0005 7018 HSEA HSEB OXY FOXA
Netflix (NFLX - Free Report) is banking on the longest running American sitcom creator to bring it more success than Twenty-First Century Fox (FOXA - Free Report) experienced with the hit show - The Simpsons. The company has roped in Matt Groening to create another Netflix original, Disenchantment, which will be available as a 10-episode series starting this Friday. The Simpsons creator brings the animated series centered “around a drunken princess, an elf and a demon.
HD FOX FB TWTR NFLX FOXA
23h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
23h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET